The Dosage of Antipsychotic Drugs in the University Departments of Psychiatry in Federation of Bosnia and Herzegovinia

Abstract

The aim of this pharmaco-epidemiological study was to establish which antipsychotic are currently in use and determine in what daily dosages these drugs are given to patients in three Psychiatric departments in the Federation of Bosnia and Herzegovina (Sarajevo, Tuzla, Mostar).

Majority of patients received classic antipsychotic medications. In Sarajevo most frequently administered was promazine, orally and parenteral, for total of 38 patients or 28, 6% of Sarajevo sample. In Tuzla most frequently, administered antipsychotics were haloperidol and thioridazine for 20 and 21 patients, which are 19, 2%, and 20, 2% of total number of patients in Tuzla. In Mostar the leading antipsychotic is haloperidol, orally administered, and with which 29 patients were treated. This represent 31,2% of total number of patients in Mostar.

Clozapine was applied in all three centres but in very small percentage of cases. Treatment with daily doses antipsychotics in the Department of Psychiatry in University Clinical Centres in Federation of Bosnia and Herzegovina are mainly in accordance with interactional standards. Only problem is area of simultaneous use of multiple antipsychotics, both in acute and chronic cases, and frequent use of antiparkinsonics in chronic cases. Because of disseminated results, were considered that the continuous medical education will lead to improvement of treatment quality for the patients with schizophrenia.